Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Dutch is a Netherlands-based investment and holding company founded by entrepreneur Peter Goedvolk, specializing in the development of innovative enterprises across the energy, logistics, and healthcare sectors. The firm’s healthcare and life sciences activities are primarily managed through its subsidiary, First Dutch Innovations (FDI), which oversees a diverse portfolio of over 20 high-tech companies. Many of these ventures are spin-offs from the Netherlands Organisation for Applied Scientific Research (TNO), focusing on medical diagnostics, biotechnology, and life science research tools. A key asset in their portfolio is Triskelion, a prominent contract research organization (CRO) that provides essential safety and efficacy testing for the pharmaceutical and chemical industries. First Dutch provides the strategic capital and operational support necessary to transition complex scientific research into viable commercial products. The company acts as a vital link between institutional research and the international healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Dutch.